Analysis: Drugmakers face more scrutiny of discordant U.S. prices
By Deena Beasley LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in...
Read More »
Call Free Talk Live now at 1-855-450-FREE
By Deena Beasley LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in...
Read More »By Bill Berkrot (Reuters) - Generic drugmaker Actavis Inc, formerly Watson Pharmaceuticals, said on Friday that it was in early stag...
Read More »
By Jessica Dye NEW YORK (Reuters) - A federal judge in New York on Friday declined to temporarily halt a court order directing the U...
Read More »By Toni Clarke (Reuters) - The Food and Drug Administration has approved a new drug to treat chronic obstructive pulmonary disease, ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Pregnant women can be reassured that cleaning with a bidet after using the toilet wil...
Read More »
By Deena Beasley LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in...
Read More »(Reuters) - Eli Lilly and Co said it will end development of an experimental cancer drug after it failed in a late-stage trial to de...
Read More »(Reuters) - Pfizer Inc said it could not decide whether to pursue regulatory approval for Pain Therapeutics Inc's painkiller Remoxy,...
Read More »
ZURICH (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serio...
Read More »
By Caroline Humer (Reuters) - Kentucky Democratic Governor Steve Beshear said on Thursday he will expand Medicaid coverage under Pre...
Read More »